乳房切除术后放疗后扩张器置换假体的最佳时机
多中心回顾性队列研究纳入298例二期乳房再造患者,探讨PMRT后扩张器置换假体的最佳时机。ROC分析确定间隔>6.87个月为最佳延迟,早期置换(<6.87个月)与更高的90天并发症率相关(14.8% vs 6.7%,P=0.025)。结论建议PMRT后至少延迟6.87个月再行二期再造以降低并发症风险。
要点
- PMRT后扩张器置换假体间隔>6.87个月可降低90天并发症风险。
- 早期置换(<6.87个月)与感染和伤口裂开风险增加独立相关。
- 将6.87个月时间窗纳入术前风险评估和决策可能改善结局。
核心结论
- PMRT后至少延迟6.87个月行二期再造与最低的90天并发症风险相关。
研究设计与样本
- 多中心回顾性队列研究,纳入2016至2025年接受PMRT后二期乳房再造的298例患者。
主要发现
- 早期置换组(<6.87个月)总体并发症率为14.8%,延迟组为6.7%(P=0.025)。
- 早期置换组主要感染率为8.7% vs 2.7%(P=0.025),伤口裂开率为9.4% vs 3.4%(P=0.033)。
- 多因素logistic回归显示早期置换与并发症风险增加独立相关(OR=2.255,95%CI:1.015-5.008,P=0.046)。
关键数值与推荐
- ROC分析确定PMRT完成至假体置换的最佳间隔延迟为>6.87个月(AUC=0.558)。
- 患者平均年龄46.2±10.2岁,BMI 25.5±5.0 kg/m2,PMRT完成至置换平均间隔8.2±5.4个月。
临床怎么用
- 在PMRT后行二期乳房再造时,建议至少等待6.87个月再行扩张器置换假体以降低并发症风险。
- 术前风险咨询中应告知患者早期置换(<6.87个月)与感染和伤口裂开风险增加相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal timing of tissue expander to implant exchange after postmastectomy radiation therapy (PMRT) remains unclear and is a source of variability in 2-stage breast reconstruction. Radiation-induced tissue changes are known to impair wound healing and increase the risk of infection, yet evidence defining a safe interval for second-stage reconstruction is limited and inconsistent across prior studies. This study aimed to identify the optimal time to undergo exchange after PMRT therapy to minimize postoperative complications. METHODS: A multicenter retrospective cohort study was conducted on patients who underwent 2-stage breast reconstruction with PMRT to the tissue expander between 2016 and 2025. The primary outcome was 90-day complication rate after permanent implant placement. Patients were excluded if they received neoadjuvant radiation therapy, PMRT to permanent implants, or did not complete the second stage of breast reconstruction. RESULTS: Final sample included 298 patients with an average age of 46.2±10.2 years and BMI of 25.5±5.0 kg/m2. The mean interval between PMRT completion and implant exchange was 8.2±5.4 months. The ROC analysis identified >6.87 months as the optimal interval delay (AUC=0.558). Patients who underwent earlier exchange (<6.87 mo) experienced an increased overall complication rate after second stage reconstruction (14.8% vs. 6.7%, P=0.025), primarily greater rates of major infection (8.7% vs. 2.7%, P=0.025) and wound dehiscence (9.4% vs. 3.4%, P=0.033). When adjusting for covariates on multivariable logistic regression, earlier exchange (<6.87 mo) remained independently associated with an increased risk of complication (OR=2.255, 95% CI: 1.015-5.008, P=0.046). CONCLUSION: This study found that delaying second stage reconstruction until at least 6.87 months after PMRT was associated with the lowest risk of 90-day complications. Incorporating this timeframe into surgical decision-making may help optimize patient outcomes and improve preoperative risk counseling.
引用
- DePamphilis MA, Chen Y, McGlynn MN, et al. Optimal Timing for Expander to Implant Exchange After Postmastectomy Radiation Therapy. Ann Plast Surg. 2026. PMID: 42424364. doi:10.1097/SAP.0000000000004803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。